C. Oliveira
13 Papers
4 Citations
C. Oliveira is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 8 publications.
Chat about Author
Papers
Antiviral activity of medicinal plant-derived products against SARS-CoV-2
Jonatas Rafael de Oliveira,Beatriz Sales Antunes,Gabriela Oliveira do Nascimento,Jaqueline Cadorini de Souza Kawall,João Victor Bianco Oliveira,Kevin Gustavo Dos Santos Silva,Mariana Aparecida de Toledo Costa,C. Oliveira +7 more
TL;DR: This review presents information from several studies that have demonstrated the antiviral activity of extracts and phytocompounds derived from medicinal plants against SARS-CoV-2 and the main findings from the research are presented.
17
Lacticaseibacillus rhamnosus modulates the inflammatory response and the subsequent lung damage in a murine model of acute lung inflammation
F. Olímpio,José Roberto Machado Cunha da Silva,Rodolfo de Paula Vieira,C. Oliveira,Flavio Aimbire +4 more
TL;DR: In this article , the anti-inflammatory effect of probiotic Lacticaseibacillus rhamnosus (Lr) on lung inflammation induced by Lipopolysaccharide (LPS) of Escherichia coli in C57BL/6 mice was investigated.
7
Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2
F. Olímpio,Robert Andreata-Santos,Paloma Cristina Rosa,Wellington Santos,C. Oliveira,Flavio Aimbire +5 more
TL;DR: In this article , the Lactobacillus rhamnosus (Lr) was used to prevent COPD exacerbation in bronchial epithelium exposed to cigarette smoke extract (CSE) and viruses.
Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials.
TL;DR: Selenium (Se) supplementation has beneficial evidence for acute respiratory diseases and should be considered as a viable option as adjuvant therapy for patients diagnosed with these pathologies.
5
A phytotherapic blend immunity-6™ inhibits myeloid leukemic cells 2 activation involving purinergic signaling.
Yanesko Bella,C. Oliveira,José Roberto Mateus-Silva,Maysa Alves Rodrigues Brandão-Rangel,Anamei Silva-Reis,Juliana de Melo Batista Santos,Regiane Albertini,Rodrigo Álvaro Brandão Lopes-Martins,Luis Vicente Franco de Oliveira,Rodolfo de Paula Vieira +9 more
- 16 Jan 2023
TL;DR: In this article , the effects of two doses of Immunity-6™, a phytocomplex composed by beta-glucan, green tea (Camelia sinensis), chamomile (Matricaria Chamomilla), and ascorbic acid (vitamin C) was tested in vitro, using chronic myelogenous leukemia cell line (K-562; 5 ×104/mL/well), which were challenged with lipopolysaccharide (LPS; 1 ug/mL) for 24 h.
2